ibh-symbol
IBH NEWS READ MORE
Back to Homepage
  • About Us
  • Resources
  • Providers
  • Members
IBH
MENU
  • Behavioral Health
    • Managed Behavioral Health
    • Substance Abuse Monitoring
    • Network Rental
    • Telehealth
  • Employer Solutions
    • Occupational Medicine
    • Workers Comp
    • Fitness for Duty
    • Professional Monitoring
    • Pre-Employment Screening
    • Medical Management & Accommodations
  • Population Health
    • Healthcare Delivery System
    • Member Engagement and Wellness
    • Patient Engagement
    • Maternity
    • Behavioral Health Screening Tools
    • Pain and Opioid Tools
  • EAP & Assistance Programs
    • Employee Assistance Program
    • Other Assistance Programs
    • Resilience Training
    • Tele-EAP
  • Research & Data
    • Data Streams
    • NAVIPPRO Research & Analytics
SEARCH GET IN TOUCH

Publications

MORE posts
Addiction Disorders Research: Characterizing Pathways of Non-oral Prescription Stimulant Non-medical Use Among Adults Recruited From Reddit
Publications
Addiction Disorders Research: Characterizing Pathways of Non-oral Prescription Stimulant Non-medical Use Among Adults Recruited From Reddit

Dr. Jodi Green, Chief Scientific Officer, Inflexxion and IBH Company, co-authored a research study. The following is an excerpt from www.frontiersin.org. Objective: Prescription stimulant non-medical use (NMU) is a national predicament. While the risks of prescription stimulant NMU have been considered, less is known about non-oral use. To focus on this gap, a sample of […]

CONTINUE READING
Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)
Publications
Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)

Based on a recent study, our team has published an article in Pain Medicine, “Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV).” For more information about this study, please see the abstract below.  To obtain the full article, click here. Abstract Objective The […]

CONTINUE READING
Abstract: Disability Claimants and the Implementation of a Web-based Pain Assessment/Pain Management Program
Publications
Abstract: Disability Claimants and the Implementation of a Web-based Pain Assessment/Pain Management Program

Based on a recent study, our team has published an article in the “PAINWeek Journal” titled, “Disability Claimants and the Implementation of a Web-based Pain Assessment/Pain Management Program.” For more information about this study, please see the abstract below.  To obtain the full article, click here. Abstract One of the most frustrating aspects of a clinician’s work is getting […]

CONTINUE READING
Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder
Publications
Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder

Based on a recent study, our team has published an article in the “Journal of Opioid Management” titled, “Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.” For more information about this study, please see the abstract below.  To obtain the full article, click here. Abstract Objective: To examine abuse […]

CONTINUE READING
Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9
Publications
Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9

Stacey A McCaffrey, PhD, Ryan A Black, PhD, Albert J Villapiano, EdD, Robert N Jamison, PhD, Stephen F Butler, PhD Pain Medicine, pnx311, https://doi.org/10.1093/pm/pnx311 Published: 11 December 2017   Abstract Objective The Current Opioid Misuse Measure (COMM) is a commonly used self-report instrument to identify and monitor aberrant opioid-related behavior in chronic pain patients on opioid therapy. However, the length […]

CONTINUE READING
Profiling non-medical use of tapentadol products among recreational drug abusers
Publications
Profiling non-medical use of tapentadol products among recreational drug abusers

Taryn Dailey-Govoni, Jared Beaumont, Theresa Cassidy Inflexxion, Inc., Waltham, MA, USA Presented at PAINWeek 2017 Read our poster for “Profiling non-medical use of tapentadol products among recreational drug abusers” here Abstract Purpose Prescription opioid misuse and abuse is a public health epidemic in the United States (ONDCP 2015) and a growing source of morbidity, mortality, […]

CONTINUE READING
The Power of an Electronic Clinical Assessment for Pain and Opioid Misuse Risk
Publications
The Power of an Electronic Clinical Assessment for Pain and Opioid Misuse Risk

Click here to read our latest article, The Power of an Electronic Clinical Assessment for Pain and Opioid Misuse Risk: Leveraging SOAPP & COMM in a Digital Era  

CONTINUE READING
PainCAS now available for Allscripts users: A pain and opioid risk assessment featuring SOAPP® & COMM®
Publications
PainCAS now available for Allscripts users: A pain and opioid risk assessment featuring SOAPP® & COMM®

Inflexxion, Inc. announced today that Allscripts has certified PainCAS™ as part of the Allscripts Developer Program. PainCAS enables Allscripts ambulatory EHR users to assess pain, functioning, and risk of problematic opioid-related behaviors in patients with chronic pain. Developed in part with support from the National Institutes of Health (NIH), grants (Grant No. R44DA026359, PI S.F. Butler and Grant No. R44DA015617, PI S.F. Butler), PainCAS is a scientifically validated web-based, patient self-report clinical tool for assessing pain and opioid misuse risk in patients with chronic pain.  

CONTINUE READING
Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8)
Publications
Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8)

Authors: Ryan A. Black, PhD, Stacey A. McCaffrey, PhD, Albert J. Villapiano, EdD, Robert N. Jamison, PhD, Stephen F. Butler, PhD Pain Medicine, pnx194, https://doi.org/10.1093/pm/pnx194 Published: 11 August 2017 Abstract Objective: Although the Screener and Opioid Assessment for Patients with Pain–Revised (SOAPP-R) has become a widely used screener for aberrant opioid-related behavior in adults, the length of the instrument may […]

CONTINUE READING
Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system
Publications
Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system

Jared Beaumont, M.P.H.1, Theresa Cassidy, M.P.H.1, Taryn Dailey Govoni, M.P.H.1 Presented at International Conference on Opioids 2017 See our poster for “Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system” here Abstract Post-market surveillance data indicate low abuse levels of tapentadol products, but research regarding the route of administration […]

CONTINUE READING
Article: How an electronic assessment tool can assist in meeting Tennessee Licensing for OBOT
Publications
Article: How an electronic assessment tool can assist in meeting Tennessee Licensing for OBOT

How an electronic assessment tool can assist in meeting Tennessee Licensing for Office-Based Opiate Treatment (OBOT) Over the last few years, we have seen many states taking the initiative and implementing new rules and regulations as a result of the opioid epidemic that is sweeping our nation.  On January 12, a new rule went into […]

CONTINUE READING
A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia
Publications
A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia

Kimberlee J. Trudeau, Joanna Burtner, Kruti Joshi, Albert Villapiano, Megan Jones, & Stephen F. Butler Presented at ARM 2016 See our poster for “A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia” here Research Objective:  In the fragmented US healthcare system, patients seeking substance abuse […]

CONTINUE READING
Load More

We drive value on your investment for your business.

REQUEST A SALES CONSULTATION

Solutions

  • Behavioral Health
  • EAP & Assistance Programs
  • Employer Solutions
  • Managed Behavioral Health
  • Member Engagement and Wellness

Services

  • Pain and Opioid Tools
  • Patient Engagement
  • Population Health
  • Research & Data
  • Resilience Training

About

  • Executives
  • Education
  • Blog
  • Careers
  • Contact Us
Privacy Policy © 2021 IBH. All rights reserved.

Recent News

IBH Acquisition of HMC HealthWorks Raises Bar for Population Health

Feb 09, 2021

IBH Population Health Solutions Completes Acquisition of HMC HealthWorks

Dec 22, 2020

IBH Announces Breakthrough Programs for Panic Attacks and PTSD in Partnership with Freespira

Dec 15, 2020

IBH Announces Industry First Program for Parenting and Childcare to Help Families Better Navigate Through Current Challenges with Work Transition and Onsite/Online Schooling

Sep 24, 2020
VIEW ALL NEWS
CLICK TO CLOSE
IBH NEWS